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Abstract: Objective: to investigate the effect of clinical pharmacists in ICU. Methods: 108 ICU patients from January 
2018 to March 2020 were divided into the control group and the observation group, with 54 cases in each group. The 
control group used the previous medication route, while the observation group introduced clinical pharmacists to guide 
clinical medication. The infection rate and adverse reaction rate of the two groups were compared. Results: the infection 
rate of the observation group was 3.70%, and that of the control group was 14.81%, which was significantly lower than 
that of the control group (P<0.05). The adverse reaction rate of the observation group was 5.56%, and that of the control 
group was 18.52%, which was significantly lower than that of the control group (P<0.05). Conclusion: the introduction 
of clinical pharmacists to guide clinical medication in ICU can effectively control the infection, and reduce various ad-
verse reactions during drug use, so as to realize the scientific and standardized use of drugs, and improve the efficiency 
and safety of drug use. 
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1. Introduction 
ICU is the abbreviation of intensive care unit, which 
mainly provides effective isolation and treatment places 
for severe and comatose patients to complete the rescue 
of patients. Generally speaking, ICU patients have a high 
degree of disease severity, and the disease changes 
quickly, so the treatment needs to be very timely and 
accurate[1]. In the hospital, the clinical drug work is gen-
erally in the charge of the hospital pharmacists. Through 
the communication between pharmacists and doctors, 
nursing staff and management personnel, the latest drug 
information is provided for the treatment of patients, the 
consultation of rational drug use is completed, and the 
rationality of drug use is improved[2]. However, at pre-
sent, Chinese pharmacists fail to give full play to their 
responsibilities, especially, the use of anti-infective drugs 
leads to the abuse of antibiotics, and increasing the inci-
dence of nosocomial infection, which is more dangerous 
for ICU patients. Therefore, it is necessary to introduce 
clinical pharmacists to guide clinical medication and 
improve the rationality of drug use[3]. This paper analyz-
es and discusses the effect of clinical pharmacist’s guid-
ance in ICU.  
2. Data and methods 
2.1 General information 
108 ICU patients from January 2018 to March 2020 
were divided into control group and observation group, 
with 54 cases in each group. In the control group, the 
ratio of male to female was 28:26. The lower limit of age 
was 20 years; the upper limit was 76 years; and the me- 
dian age was (48.21 ± 4.33) years. There were 14 cases 
in neurosurgery, 16 cases in general surgery, 18 cases in
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thoracic surgery and 6 cases in orthopedics[4]. In the ob-
servation group, the ratio of male to female was 29:25. 
The lower limit of age was 19 years; the upper limit 
was 76 years; the median age was (47.86 ± 4.59) years. 
There were 15 cases in neurosurgery, 14 cases in general 
surgery, 19 cases in thoracic surgery and 6 cases in or-
thopedics. There was no significant difference in basic 
data between the two groups (P > 0.05). 
2.2 Method 
In the control group, the previous drug management 
mode was still used. After obtaining the prescription, the 
drug was reviewed and distributed according to the pre-
scription after it was confirmed to be correct. 
The specific measures are as follows: (1) clinical 
pharmacists need to enter the ICU every day to make 
rounds with the attending doctors, often make acute in-
spections on patients and obtain the latest results of pa-
tients’ examinations. It’s necessary to timely judge the 
abnormality of disease treatment, and whether the pa-
tients have bad psychology, if so, it needs actively com-
municate, give pharmaceutical care, and take good med-
ication, to ensure the standardization of clinical 
medication. (2) In general, the utilization rate of antibi-
otics is high in clinic, and the treatment of diseases is 
mainly anti infection. Pharmacists need to provide rea-
sonable medication suggestions and monitoring points, 
and pay attention to the standardization of combined 
medication. If patients are older, they need to consider 
the age problem, pay attention to the indicators of kidney 
examination and adjust the drug dose in time, so as to 
pay attention to control the adverse reactions during the 
use of drugs, and report and analyze the adverse reac-
tions in time. (3) We should pay attention to the guidance 
of drug use for nursing staff, and observe whether the 
administration method of nursing staff is correct. Alt-
hough comatose patients have difficulty in swallowing, 
enteric coated drugs can’t be taken after crushing, so as 
to prevent the efficacy from being affected. In severe 
cases, toxic reactions will occur. Therefore, it is neces-
sary to replace the drugs, so as to provide more targeted 
drug intervention measures for patients. (4) We should 
join in the procurement and evaluation of new drugs, 
establish a patient-centered drug intervention mode, and 
get in touch with the drug storehouse purchasing per-
sonnel to master the clinical feedback of new drugs, so as 
to make clear the drugs in the hospital, carry out clinical 
medication guidance with the patient as the center 
and better realize pharmaceutical care. 
2.3 Observation indexes 
First, the infection rates of the two groups were an-
alyzed, including pulmonary infection, urinary system 
infection and respiratory tract infection. 
Secondly, the adverse reaction rates of the two 
groups were analyzed, including diarrhea, nausea and 
vomiting and stress ulcer. 
2.4 Statistical analysis 
The data of each observation index were qualitative 
data; n (%) was used to represent count data,  test; 
(X� ± s) was used to represent measurement data, and t 
means test. After statistical analysis by SPSS22.0 statis-
tical soft package, if the difference was significant and P 
< 0.05, it was statistically significant. 
3. Results 
3.1 Analyzing the infection rate of the two 
groups 
The infection rate of the observation group was 
3.70%, and that of the control group was 14.81%, which 
was significantly lower than that of the control group (P 
< 0.05). See Table 1 for details. 
 
Table 1. The infection rate of the two groups is analyzed 
2x






Control group (n=54) 2 3 3 14.81 
Observation group (n=54) 1 0 1 3.70 
 -- -- -- 3.967 
P -- -- -- 0.046 
2x
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3.2 The adverse reaction rates of the two 
groups are analyzed 
The adverse reaction rate of the observation group  
was 5.56%, and that of the control group was 18.52%, 
which was significantly lower than that of the control 
group (P < 0.05). See Table 2 for details. 
 
 
Table 2. Analysis of adverse reaction rate of the two groups
 
4. Discussion 
ICU patients are badly ill, so patients generally need 
to be combined with drugs. And because the immune 
system is damaged, leading to a high incidence of infec-
tion, so for patients, scientific and reasonable drug use is 
very important to ensure the safety of drug use[5]. Phar-
macists can guide the interaction, contraindications and 
compatibility of drugs, to improve the rationality of drug 
use. 
According to the data analysis in Table 1-2 above, 
the infection rate of the observation group was 3.70%, 
and that of the control group was 14.81%, which was 
significantly lower than that of the control group (P < 
0.05). The adverse reaction rate of the observation group 
was 5.56%, and that of the control group was 18.52%, 
which was significantly lower than that of the control 
group (P < 0.05). Analyzing the reasons: clinical phar-
macists have rich pharmaceutical knowledge, and can 
design safer and more reasonable drug treatment plans 
with doctors[5]. Therefore, pharmacists participating in 
clinical work can help doctors determine the dosage of 
drugs and their adverse reactions, and help doctors solve 
the adverse reactions during drug treatment, so they can 
control the adverse reactions. After drug intervention, the 
use of antibiotics can be more standardized, and the 
treatment of drugs is more targeted, so the control effect 
of infection is more ideal[6]. Using drug intervention and 
controlling acid inhibitors at the same time can better 
adjust the gastric acid and control the incidence of stress 
ulcer, so drug guidance of clinical medication can give 
full play to its advantages. They can use their own basic 
knowledge of medicine, chemistry and drug analysis to 
choose more standardized drug regimen for patients, and 
which is conducive to the recovery of ICU patients[7]. 
In conclusion, the introduction of clinical pharma-
cists to guide clinical medication in ICU can effectively 
control infection and reduce various adverse reactions 
during drug use, so as to achieve scientific and standard-
ized use of drugs and improve drug use efficiency and 
safety. 
References 
1. Liao Y, Li F, Yan J, et al. The role of clinical phar-
macists in the anti-infective treatment of ICU pa-
tients with septic shock. Chinese pharmacy 2020; 
31(11): 1382–1386.  
2. Chen X, Zhang J. Analysis of clinical pharmacists’ 
intervention on 156 inpatient orders in ICU. Chi-
nese pharmacy 2014; 25(22): 2031–2034.  
3. Shi Y. Practice and experience of clinical pharma-
cists participating in pharmaceutical care for ICU 
patients with severe infection. Chinese pharmacy 
2012; 23(26): 2494–2496. 
4. Zhao N, Shi Y, Liu G, et al. Experience of clinical 
pharmacist participating in the treatment of one 
case of acute ivermectin poisoning. Journal of clin-
ical drug therapy 2018; 16(9): 90–92.  
5. Wang H, Zhang K, Liu N, et al. Identification and 
pharmaceutical intervention of potential drug inter-
actions in ICU by clinical pharmacists. Chinese 
journal of hospital pharmacy 2018; 38(16): 1747–
1749, 1758.  
6. Liu Y, Che X, Gan L, et al. Construction and ex-
ploration of clinical pharmacist training mode of 
traditional Chinese medicine guided by critical care 
medicine department. Chinese journal of hospital 
pharmacy 2019; 39(13): 1317–1321.  
7. Li J, Zhu D. Clinical pharmacists involved in a case 
of ectopic ACTH syndrome complicated with As-
pergillus fumigatus infection. Journal of medical 
forum 2020; 41(6): 64–67. 
Group  Diarrhea (n) Nausea and vomiting (n) Stress ulcer (n) Infection rate (%) 
Control group (n=54) 4 3 3 18.52 
Observation group (n=54) 1 1 1 5.56 
 -- -- -- 4.185 
P -- -- -- 0.038 
2x
